(Q73127357)

English

An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine

scientific article published on 01 January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

author name string

Robert T Schoen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Terry Deshefy-Longhi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Christian Van-Hoecke

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Charles Buscarino

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Erol Fikrig

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

210-224

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Underreporting of Lyme disease by Connecticut physicians, 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The public health impact of Lyme disease in Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternative vaccination schedules (0, 1, and 6 months versus 0, 1, and 12 months) for a recombinant OspA Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990027-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)90027-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12637121%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73127357&oldid=1753666088"